http://orcid.org/0000-0001-5871-299X
About the Authors
- Ryan S. Noyce
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Medical Microbiology & Immunology and Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada
- Seth Lederman
-
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliation Tonix Pharmaceuticals, Inc., New York, New York, United States of America
- David H. Evans
-
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing
* E-mail: devans@ualberta.ca
Affiliation Department of Medical Microbiology & Immunology and Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada
Competing Interests
We have read the journal’s policy and the authors of this manuscript have the following competing interests: DHE and RDN provide consultation services to Tonix Pharmaceuticals Ltd. SL is the co-founder, CEO and chairman of Tonix Pharmaceuticals Ltd. A US patent application (Synthetic chimeric poxviruses; Application No.: 62/434,794; first provisional filed November 2, 2016) has been filed on behalf of the Governors of the University of Alberta and Tonix Pharmaceuticals claiming the three authors as co-inventors. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The DNAs and reconstructed HPXV strains can be provided upon request. Please direct all such enquiries to Dr. S. Lederman, c/o Tonix Pharmaceuticals.